or
forgot password

    • cancer clinical trials in hinsdale, IL

    • IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

    Hinsdale, Illinois 60521
    Prostate Cancer, Prostatic Neoplasm
    Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

    Hinsdale, Illinois 60521
    Pain, Advanced Cancer
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Gynecologic Oncology
    Hinsdale, Illinois 60521
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
    Gynecologic Oncology
    Hinsdale, Illinois 60521
    Cervical Cancer, Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexuality and Reproductive Issues
    Patient Reported Symptoms in Ovarian Cancer (PRECISION)

    Hinsdale, Illinois 60521
    Ovarian Cancer
    Study of Ruxolitinib in Pancreatic Cancer Patients

    Hinsdale, Illinois 60521
    Metastatic Pancreatic Adenocarcinoma
    Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer

    Hinsdale, Illinois 60521
    Breast Cancer, Cancer Survivor, Hot Flashes
    Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects

    Hinsdale, Illinois 60521
    Idiopathic Thrombocytopenic Purpura, Thrombocytopenia, Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP), Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP), Thrombocytopenic Purpura
    Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    Sudarshan K Sharma MD Limted-Gynecologic Oncology
    Hinsdale, Illinois 60521
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate

    Hinsdale, Illinois 60521
    Metastatic Castration-resistant Prostate Cancer, Metastatic Breast Cancer
    Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

    Hinsdale, Illinois 60521
    Prostate Cancer, Castration Resistant Prostate Cancer, Pain, Prostatic Neoplasms
    Methotrexate or Dactinomycin in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia
    Gynecologic Oncology
    Hinsdale, Illinois 60521
    Gestational Trophoblastic Tumor
    Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Sudarshan K Sharma MD Limted-Gynecologic Oncology
    Hinsdale, Illinois 60521
    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    Hinsdale Hematology Oncology Associates Incorporated
    Hinsdale, Illinois 60521
    Breast Cancer
    Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum Sensitive Ovarian Cancer Patients
    Dr. Sudarshan K. Sharma, Ltd.
    Hinsdale, Illinois 60521
    Ovarian Cancer
    Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
    Sudarshan K Sharma MD Limted-Gynecologic Oncology
    Hinsdale, Illinois 60521
    Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma
    Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer
    Sudarshan K Sharma MD Limted-Gynecologic Oncology
    Hinsdale, Illinois 60521
    Cervical Cancer, Lymphedema, Sexuality and Reproductive Issues
    VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
    Sudarshan K. Sharma, MD, LTD
    Hinsdale, Illinois 60521
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
    A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy

    Hinsdale, Illinois 60521
    Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer
    Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
    Sudarshan K Sharma MD Limted-Gynecologic Oncology
    Hinsdale, Illinois 60521
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer